All news
Medium ImpactPharma

Torrent Pharma gets FDA approval for new drug

AD HOC NEWSRead the original19 May 2026

Torrent Pharma gets FDA approval for new drug — The company received FDA nod for its Valsartan tablets, boosting its U.S. generics portfolio. This approval enhances export potential and may contribute to revenue growth. Market reaction expected positive on volume support.

📊 STOCKS: TORNTPHARM | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #FDA

#FDA#approval#pharma
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.